Media & Resources

Filter by

  • Type

  • Health area

  • Location

  • Topic

  • Year

  • Journal

  • Publication

  • Fact sheet & publication type

  • Clear all

Press Releases

IAVI, Merck KGaA, Darmstadt, Germany, and Serum Institute of India Join Forces to Develop Monoclonal Antibodies for COVID-19 and Ensure Prompt and Equitable Global Access

October 22, 2020

Partners aim to provide potent neutralizing antibodies for COVID-19 pandemic response.

Read more

In The News

Scientists build on HIV research in bid to stop snakebite deaths

Devex

October 21, 2020

Read more

Features

What are monoclonal antibodies, and can they treat COVID-19?

October 8, 2020

Monoclonal antibodies have changed the way we treat many diseases. They are a promising treatment for COVID-19, and IAVI is committed to developing SARS-CoV-2 antibodies that will be globally accessible. 

Read more

Scientific Publications

Comparison of HIV Risk Behaviors Between Clinical Trials and Observational Cohorts in Uganda

Read more

Features

International Journal of Epidemiology publishes cohort profile of IAVI’s longitudinal HIV infection studies in Africa

September 28, 2020

Resulting knowledge and capacity continue to advance HIV vaccine research globally.

Read more

In The News

Merck, advancing single-dose and oral coronavirus vaccines, could still make Warp Speed: Bloomberg

Fierce Pharma

September 26, 2020

Read more

Features

What we learned from our “Ask the Experts: COVID-19” webinar series

September 22, 2020

Expert insights on a range of issues related to COVID-19, including media communication, community engagement, and mental health.

Read more

In The News

Four Ways To Increase Global Access To Promising Monoclonal Antibodies For COVID-19

September 22, 2020

Read more